Anticoagulant effects of a Cannabis extract in an obese rat model

Phytomedicine

Volumn 14, Issue 5, 2007, Pages 333-337

  Coetzee, C ^a   Levendal, R A ^a   van de Venter, M ^a   Frost, C L ^a  

^a NELSON MANDELA METROPOLITAN UNIVERSITY   (South Africa)

Author keywords

Anticoagulant; Blood coagulation; Cannabinoids; Cannabis; Obesity

Indexed keywords

CANNABINOID DERIVATIVE; CANNABIS; TETRAHYDROCANNABINOL; THROMBIN;

ANIMAL MODEL; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; HYPERCOAGULABILITY; IC 50; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT;

ANIMALS; ANTICOAGULANTS; BLOOD COAGULATION; CANNABINOIDS; CANNABIS; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; INHIBITORY CONCENTRATION 50; INJECTIONS, SUBCUTANEOUS; OBESITY; PHYTOTHERAPY; PLANT EXTRACTS; RATS; THROMBIN;

CANNABIS; CANNABIS SATIVA; RATTUS;

EID: 34247497684     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2006.02.004     Document Type: Article

References (21)

1. Ashton C.H. Pharmacology and effects of cannabis: a brief review. Br. J. Psychiatry 178 (2001) 101-106
2. Berry E.M., and Mechoulam R. Tetrahydrocannabinol and endocannabinoids in feeding and appetite. Pharmacol. Ther. 95 (2002) 185-190
3. Braud S., Bon C., Touqui L., and Mounier C. Activation of rabbit blood platelets by anandamide through its cleavage into arachidonic acid. FEBS Lett. 471 (2000) 12-16
4. Creager M.A., Luscher T.F., Consentino F., and Beckman J.A. Diabetes and vascular disease: pathophysiology, clinical consequences and medical therapy: Part 1. Circulation 108 (2003) 1527-1532
5. Deusch E., Kress H.G., Kraft B., and Kozek-Langenecker S.A. The procoagulatory effects of delta-9-tetrahydrocannabinol in human platelets. Anesth. Analg. 99 (2004) 1127-1130
6. Formukong E.A., Evans A.T., and Evans F.J. The inhibitory effects of cannabinoids, the active constituents of Cannabis sativa L. on human and rabbit platelet aggregation. J. Pharm. Pharmacol. 41 (1989) 705-709
7. Katzung B.G. Basic and Clinical Pharmacology. fourth ed (1989), Prentice-Hall, London pp. 391-393
8. Levy R., and Livne A. Mode of action of hashish compounds in reducing blood platelet count. Biochem. Pharmacol. 25 (1976) 359-360
9. Liu S., Zhou F., Höök M., and Carson D.D. A heparin-binding synthetic peptide of heparin/heparan sulfateinteracting protein modulates blood coagulation activities. Proc. Natl. Acad. Sci. USA 94 (1997) 1739-1744
10. Maccarone M., Bari M., Menichelli A., Del Principe D., and Agro A.F. Anandamide activates human platelets through a pathway independent of the arachidonate cascade. FEBS Lett. 447 (1999) 277-282
11. Michelson A.D., Barnard M.R., Krueger L.A., Valeri C.R., and Furman M.I. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin circulation 104 (2001) 1533-1537
12. 9- tetrahydrocannabinol mediated by peroxisome proliferators-activated receptor gamma. Biochem. Biophys. Res. Comm. 337 (2005) 824-831
13. Pertwee R.G. Cannabis and cannabinoids: pharmacology and rationale for clinical use. Forsch Komplementärmed 6 Suppl 3 (1999) S12-S15
14. Radhakrishnamurthy B., Smart F., Dalferes E.R., and Berenson G.S. Isolation and characterization of proteoglycans from bovine lung. J. Biol. Chem. 255 (1980) 7575-7582
15. Schaeffer C.F., Brackett D.J., Gunn C.G., and Dubowski K.M. Decreased platelet aggregation following marijuana smoking in man. Journal of Oklahoma State Medical Association 72 (1979) 435-436
16. Steffens S., Vellard N.R., Arnaud C., Pelli G., Burger F., Staub C., Zimmer A., Frossard J.L., and Mach F. Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice. Nature 434 (2005) 782-786
17. Tholstrup T., Miller G.J., Bysted A., and Sandstrom B. Effect of individual dietary fatty acids on postprandial activation of blood coagulation factor VII and fibrinolysis in healthy young men. Am. J. Clin. Nutr. 77 (2003) 1125-1132
18. Turner J.C., and Mahlberg P.G. Separation of Acid and neutral cannabinoids in Cannabis sativa L. using HPLC. In: Agurell S., Dewey W.L., and Willete R.E. (Eds). Chemical, Pharmacol. Ther. Agents (1984), Academic Press, USA 79-88
19. Van Wyk B., and Gericke N. Peoples Plants: A Guide to Useful Plants of Southern Africa (2000), Briza Publications, Pretoria, South Africa p. 158
20. Vinik A.I., Erbas T., Park T.S., Nolan R., and Pittenger G.L. Platelet dysfunction in type 2 diabetes. Diabetes Care 24 (2001) 1476-1485
21. Williamson E.M., and Evans F.J. Cannabinoids in clinical practice. Drugs 60 (2000) 1303-1314